APOC - multiplexed acoustic point of care diagnostic system for STIs

SAW-Dx有限公司是一家新兴的点护理（POC）诊断设备设计和制造公司，采用超声波技术的专有创新。该项目将进一步实现SAW-Dx的目标，以满足对性传播感染的POC诊断测试日益增长的需求。目前，疾病控制中心估计，仅在美国，每年就有2000万新的性传播感染病例。我们建议我们的声流技术将成为性病快速核酸检测（NAT）的基础。一旦得到证实，该技术在未来也有可能进入其他POC诊断市场（例如结核病和丙型肝炎病毒）。该项目将建立并验证一个原型（便携式读取器和一次性墨盒），以驱动诊断测试结果，样品进入测试设备（或“芯片”）后，无需用户干预，30分钟内。这将使患者能够立即得到治疗（目前患者必须在几天后返回以获得结果-许多人不这样做）。我们未来的目标是看到我们的平台被许多不同的医疗保健市场所采用——因为它的简单性使其具有跨平台兼容性。

SAW-Dx Ltd is an emerging point-of-care (POC) diagnostic device design and manufacturing company, using proprietary innovations around ultrasonic technologies. This project will further the ambition of SAW-Dx to meet the growing demand for POC diagnostic tests for sexually transmitted infections. Currently the Center for Disease Control estimate >20M new STIs every year, in the US alone. We propose that our Acoustic-Flow technology will form the basis of a rapid nucleic acid test (NAT) for STIs. Once demonstrated, the technology also has potential to reach into other POC diagnostics markets (including e.g. tuberculosis and HCV) in the future. This project will build and validate a prototype (portable reader and disposable cartridge) to drive a diagnostic test to a result, with no user intervention after the sample enters the test device (or “chip”), within 30 min. This will enable the immediate treatment of the patient (currently patients must return to obtain their results after several days – many do not). Our future ambitions will see our platform being adopted into a number of different healthcare markets - as its simplicity lends itself to cross-platform compatibility.